页面版权：贝塔医药科技有限公司
�
0
Changsha Beita
Changsha Beta Pharmatech Co., Ltd. (CBP) is registered and entered into Wufeng Science and Technology Park, Changsha National Economic and Technological Development Zone, in November 2013.
CBP is established on the base of Wuxi Beita isotope labeled products from the stage of research and development into the stage of industrialization and Kaiwu Venture Capital joining in, and it was positioned for the Beta Headquarter.
The registered capital of CBP was 14.9 million yuan. CBP has newly renovated 1,500 square meters laboratories equipped with synthetic and labeling devices and advanced analytic instruments, as well as a specially trained isotope labeling team.
CBP's main business is to localize isotope labeled internal standards for detecting proteomics-related diseases, such as stable isotope labeled amino acids and L-carnitine derivatives for detecting newborns genetic metabolic diseases, and so on.
CBP is developing quickly on the bases of the resources, experience and technologies established by WBP. Its advantages are as follows:
CBP is established on the base of Wuxi Beita isotope labeled products from the stage of research and development into the stage of industrialization and Kaiwu Venture Capital joining in, and it was positioned for the Beta Headquarter.
The registered capital of CBP was 14.9 million yuan. CBP has newly renovated 1,500 square meters laboratories equipped with synthetic and labeling devices and advanced analytic instruments, as well as a specially trained isotope labeling team.
CBP's main business is to localize isotope labeled internal standards for detecting proteomics-related diseases, such as stable isotope labeled amino acids and L-carnitine derivatives for detecting newborns genetic metabolic diseases, and so on.
CBP is developing quickly on the bases of the resources, experience and technologies established by WBP. Its advantages are as follows:
1、The domestic unique hundreds of isotope labeling precursors preparation process can ensure to provide rapidly intermediates needed in labeling synthesis.
2、The imported and advanced analytic and detective instruments can ensure to analyze and detect timely the labeling products.
3、The core TEFLON line technology and the series of patents can ensure the synthesis technologies to be advanced and unique.
4、The partnership with domestic and foreign prestigious enterprises can ensure to makeup company’s weekness and make the company fully developed.
5、The international management team can ensure to do the cooperation with profession and integrity.
6、The domestic and foreign experts can ensure to have continuous technology innovations.
7、The urgently needed domestic products can ensure to keep market potential and economic benefits.
8、The huge domestic market potential can ensure to have the driving force for sustainable development.
2、The imported and advanced analytic and detective instruments can ensure to analyze and detect timely the labeling products.
3、The core TEFLON line technology and the series of patents can ensure the synthesis technologies to be advanced and unique.
4、The partnership with domestic and foreign prestigious enterprises can ensure to makeup company’s weekness and make the company fully developed.
5、The international management team can ensure to do the cooperation with profession and integrity.
6、The domestic and foreign experts can ensure to have continuous technology innovations.
7、The urgently needed domestic products can ensure to keep market potential and economic benefits.
8、The huge domestic market potential can ensure to have the driving force for sustainable development.
The company is in the stage of industrializing the isotope labeled products and technologies. We welcome your involvements by investment, participation, and cooperation.
The company's five-year development goal is to build an industrial base of producing a series of isotope labeled internal standards for various diseases detection in China, become the leading enterprise in the detection field, promote the developments of medicinal industry, and provide helps for new drug discovery, biotech, agriculture, environmental protection and chemistry domestically, and make greater contributions to Chinese and human health.
The company's five-year development goal is to build an industrial base of producing a series of isotope labeled internal standards for various diseases detection in China, become the leading enterprise in the detection field, promote the developments of medicinal industry, and provide helps for new drug discovery, biotech, agriculture, environmental protection and chemistry domestically, and make greater contributions to Chinese and human health.